MODEL VERDICT
Praxis Precision Medicines, Inc. (PRAX)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| Feb 14, 2026 | NEUTRAL | 0.15 | $317.25 | CURRENT | +7.1% |
| Feb 11, 2026 | NEUTRAL | 0.15 | $320.48 | Below threshold | -1.4% |
| Jan 11, 2026 | NEUTRAL | 0.20 | $288.45 | Below threshold | +9.6% |
| Dec 12, 2025 | NEUTRAL | 0.20 | $268.80 | Below threshold | +12.9% |
| Nov 12, 2025 | NEUTRAL | 0.19 | $183.61 | Below threshold | +74.0% |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/TBV | 3.21 | 2.60 | 1.44 | 7.55 | 2.26 |
| P/B Ratio | 3.21 | 2.60 | 1.44 | 7.55 | 2.26 |
Insufficient data to determine relative valuation for PRAX.
Fair value could not be computed for PRAX due to insufficient comparable data.
PRAX's current P/E of -24.1x compares to the industry median of 18.3x (2 peers in the group). This represents a -231.3% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
16 analysts cover PRAX with a consensus rating of Buy. The consensus price target is $544.40 (range: $83.00 — $843.00), implying +67.9% upside from the current price. Grade breakdown: Strong Buy (0), Buy (12), Hold (3), Sell (1), Strong Sell (0).
The model confidence score is 49/100, based on: data completeness (0), peer quality (25), historical depth (16), earnings stability (5), and model agreement (3). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for PRAX.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.